Jilin Province Xidian Pharmaceutical SciTech Development Co.,Ltd
- Country
- Ownership
- -
- Established
- 1990-03-21
- Employees
- 269
- Market Cap
- -
- Website
- http://www.xidianyy.com
- Introduction
The company is a technology-based pharmaceutical enterprise focusing on R&D, production and sales of chemical raw materials and formulations. It is one of the first pharmaceutical companies in Jilin Province to pass the “High-tech Enterprise” certification in 2008. It has also been successively rated as a “National High-tech Enterprise” and a “National Torch Program Key High-tech Enterprise”. After more than 30 years of differentiated development, the company has formed a product system with anti-anemia drugs, drugs for treating mental disorders, and raw materials as the core, and auxiliary drugs for cardiovascular diseases and drugs for anti-tumor treatment. The company is mainly engaged in R&D, production and sales of chemical raw materials and formulations. The company's main products include compound ferrous sulfate folic acid tablets, risperidone tablets, escitalopram oxalate tablets, rexianthin capsules, ferrous fumarate, ferrous sulfate, and reflavin.
Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
52
Drug Approvals
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20253429
- Approval Date
- Feb 20, 2025
Risperidone Orally Disintegrating Tablets
- Product Name
- 可同
- Approval Number
- 国药准字H20247236
- Approval Date
- Sep 30, 2024
Risperidone Orally Disintegrating Tablets
- Product Name
- 可同
- Approval Number
- 国药准字H20247235
- Approval Date
- Sep 30, 2024
Rivastigmine Bitartrate Oral Solution
- Product Name
- 重酒石酸利斯的明口服溶液
- Approval Number
- 国药准字H20244273
- Approval Date
- Jun 28, 2024
Roxatidine Acetate Hydrochloride for Injection
- Product Name
- 注射用盐酸罗沙替丁醋酸酯
- Approval Number
- 国药准字H20234148
- Approval Date
- Sep 12, 2023
Esmolol Hydrochloride Injection
- Product Name
- 盐酸艾司洛尔注射液
- Approval Number
- 国药准字H20233872
- Approval Date
- Jun 30, 2023
Soldium Ozagrel for Injection
- Product Name
- 注射用奥扎格雷钠
- Approval Number
- 国药准字H20041261
- Approval Date
- Sep 11, 2020
Soldium Ozagrel for Injection
- Product Name
- 注射用奥扎格雷钠
- Approval Number
- 国药准字H20041260
- Approval Date
- Sep 11, 2020
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next